Global Rivaroxaban Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026

  • ID:PD006010
  • October 2020
  • Value Market Research
                          

The report on the Global Rivaroxaban Market gives an estimation of the development of the market based on historical studies and also provides forecasts on the basis of a comprehensive research. The report gives a complete market analysis for the forecasted period from 2020 to 2026. The market is divided into various segments with an in-depth outlook of the competitors and a listing of the profiled key players. The market size in terms of revenue (USD MN) is calculated and provided for the study period along with the dynamics of the market such as the drivers and the restraints.
 
Drivers

  • Increasing adoption rivaroxaban for the treatment and preservation of embolism and non-hemorrhagic stroke.
  • Rising number of hip and knee replacement surgeries globally.
 
Restraints
  • Patent expiration of the drug Xarelto.
 
Furthermore, the report quantifies the market share held by the major players of the industry and provides an in-depth view of the competitive landscape. This market is classified into different segments with detailed analysis of each with respect to geography for the study period:
 
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Till: 2026
 
The comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved. The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.
 
The report classifies the market into different segments based on strength, application and distribution channel. These segments are studied in detail incorporating the market estimates and forecasts at regional and country level. The segment analysis is useful in understanding the growth areas and probable opportunities of the market.
 
The report also covers the complete competitive landscape of the global Rivaroxaban market with company profiles of key players such as:
 
  • Bayer
  • J&J
 
A detailed description of each has been included, with information in terms of H.Q, future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other latest industrial developments.
 
SEGMENTATIONS IN THE REPORT:
By Strength
  • 10 mg
  • 15 mg
  • 20 mg
 
By Application
  • Deep Vein Thrombosis Prophylaxis
  • Pulmonary Embolism
 
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
 
By Geography:
  • North America (NA) - US, Canada, and Mexico
  • Europe (EU) - UK, Germany, France, Italy, Russia, Spain & Rest of Europe
  • Asia-Pacific (APAC) - China, India, Japan, South Korea, Australia & Rest of APAC
  • Latin America (LA) - Brazil, Argentina, Peru, Chile & Rest of Latin America
  • Middle East and Africa (MEA) - Saudi Arabia, UAE, Israel, South Africa
 
The Global Rivaroxaban Market has been exhibited in detail in the following chapters -
Chapter 1 Rivaroxaban Market Preface
Chapter 2 Executive Summary
Chapter 3 Rivaroxaban Industry Analysis
Chapter 4 Rivaroxaban Market Value Chain Analysis
Chapter 5 Rivaroxaban Market Analysis By Strength
Chapter 6 Rivaroxaban Market Analysis By Application
Chapter 7 Rivaroxaban Market Analysis By Distribution Channel
Chapter 8 Rivaroxaban Market Analysis By Geography
Chapter 9 Competitive Landscape Of Rivaroxaban Companies
Chapter 10 Company Profiles Of Rivaroxaban Industry

TABLE OF CONTENTS
 
1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Rivaroxaban Market
       2.2. Global Rivaroxaban Market Snapshot
 
3 . RIVAROXABAN – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Rivaroxaban Market
       3.3. Market Restraints of Rivaroxaban Market
       3.4. Opportunities of Rivaroxaban Market
       3.5. Trends of Rivaroxaban Market
       3.6. Porter’s Five Force Analysis of Rivaroxaban Market
       3.7. Rivaroxaban Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Strength
           3.7.2 Market Attractive Analysis by Application
           3.7.3 Market Attractive Analysis by Distribution Channel
           3.7.4 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Rivaroxaban Value Chain Analysis
       4.2. Rivaroxaban Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Rivaroxaban Raw Material Manufactures List
           4.2.3. Price Trend of Rivaroxaban Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak on Rivaroxaban Market
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Rivaroxaban Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Rivaroxaban Market Size in 2020, by Scenario
       5.5. COVID-19: Micro and Macro Factor Analysis on Rivaroxaban Market
 
6 . GLOBAL RIVAROXABAN MARKET ANALYSIS BY STRENGTH
       6.1 Overview by Strength
       6.2 Historical Data 2015-2018
       6.3 Global Rivaroxaban Market Analysis by Strength
 
7 . GLOBAL RIVAROXABAN MARKET ANALYSIS BY APPLICATION
       7.1 Overview by Application
       7.2 Historical Data 2015-2018
       7.3 Global Rivaroxaban Market Analysis by Application
       7.4 Market Analysis of Deep Vein Thrombosis Prophylaxis by Regions
       7.5 Market Analysis of Pulmonary Embolism by Regions
 
8 . GLOBAL RIVAROXABAN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
       8.1 Overview by Distribution Channel
       8.2 Historical Data 2015-2018
       8.3 Global Rivaroxaban Market Analysis by Distribution Channel
       8.4 Market Analysis of Hospital Pharmacies by Regions
       8.5 Market Analysis of Retail Pharmacies by Regions
       8.6 Market Analysis of Online Pharmacies by Regions
 
9 . GLOBAL RIVAROXABAN MARKET ANALYSIS BY GEOGRAPHY
       9.1. Regional Outlook
       9.2. Introduction
       9.3. North America
           9.3.1. Overview and Historic Data
           9.3.2. North America Rivaroxaban Market Estimate By Market Segment
           9.3.3. North America Rivaroxaban Market Estimate By Country
           9.3.4. United State
           9.3.5. Canada
           9.3.6. Mexico
       9.4. Europe
           9.4.1. Overview and Historic Data
           9.4.2. Europe Rivaroxaban Market Estimate by Market Segment
           9.4.3. Europe Rivaroxaban Market Estimate by Country
           9.4.4. United Kingdom
           9.4.5. France
           9.4.6. Germany
           9.4.7. Italy
           9.4.8. Russia
           9.4.9. Rest Of Europe
       9.5. Asia Pacific
           9.5.1. Overview and Historic Data
           9.5.2. Asia Pacific Rivaroxaban Market Estimate by Market Segment
           9.5.3. Asia Pacific Rivaroxaban Market Estimate by Country
           9.5.4. China
           9.5.5. India
           9.5.6. Japan
           9.5.7. South Korea
           9.5.8. Australia
           9.5.9. Rest Of Asia Pacific
       9.6. Latin America
           9.6.1. Overview and Historic Data
           9.6.2. Latin America Rivaroxaban Market Estimate by Market Segment
           9.6.3. Latin America Rivaroxaban Market Estimate by Country
           9.6.4. Brazil
           9.6.5. Argentina
           9.6.6. Peru
           9.6.7. Chile
           9.6.8. Rest of Latin America
       9.7. Middle East & Africa
           9.7.1. Overview and Historic Data
           9.7.2. Middle East & Africa Rivaroxaban Market Estimate by Market Segment
           9.7.3. Middle East & Africa Rivaroxaban Market Estimate by Country
           9.7.4. Saudi Arabia
           9.7.5. UAE
           9.7.6. Israel
           9.7.7. South Africa
           9.7.8. Rest Of Middle East And Africa
 
10 . COMPETITIVE LANDSCAPE OF THE RIVAROXABAN COMPANIES
       10.1. Rivaroxaban Market Competition
       10.2. Partnership/Collaboration/Agreement
       10.3. Merger And Acquisitions
       10.4. New Product Launch
       10.5. Other Developments
 
11 . COMPANY PROFILES OF RIVAROXABAN INDUSTRY
       11.1. Company Share Analysis
       11.2. Market Concentration Rate
       11.3. Bayer
           11.3.1. Company Overview
           11.3.2. Financials
           11.3.3. Products
           11.3.4. Recent Developments
       11.4. J&J
           11.4.1. Company Overview
           11.4.2. Financials
           11.4.3. Products
           11.4.4. Recent Developments
 
 *Note - In company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Rivaroxaban Market Snapshot
  • Drivers of The Global Rivaroxaban Market Impact Analysis
  • Restraints of The Global Rivaroxaban Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Rivaroxaban Market: Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Rivaroxaban Market Size In 2020, By Scenario
  • COVID-19: Micro and Macro Factor Analysis on Rivaroxaban Market
  • Global Rivaroxaban Market Analysis by Strength (USD MN)
  • Historic Data 2015-2018
  • Global Rivaroxaban Market Analysis by Application (USD MN)
  • Historic Data 2015-2018
  • Global Rivaroxaban Market Analysis in Deep Vein Thrombosis Prophylaxis by Geography (USD MN)
  • Global Rivaroxaban Market Analysis in Pulmonary Embolism by Geography (USD MN)
  • Global Rivaroxaban Market Analysis by Distribution Channel (USD MN)
  • Historic Data 2015-2018
  • Global Rivaroxaban Market Analysis in Hospital Pharmacies by Geography (USD MN)
  • Global Rivaroxaban Market Analysis in Retail Pharmacies by Geography (USD MN)
  • Global Rivaroxaban Market Analysis in Online Pharmacies by Geography (USD MN)
  • Historic Data 2015-2018
  • Global Rivaroxaban Market by Geography (USD MN)
  • Historic Data 2015-2018
  • North America Rivaroxaban Market Analysis by Strength (USD MN)
  • North America Rivaroxaban Market Estimate by Application (USD MN)
  • North America Rivaroxaban Market Analysis by Distribution Channel (USD MN)
  • North America Rivaroxaban Market Estimate by Country (USD MN)
  • United State Rivaroxaban Market Analysis by Strength (USD MN)
  • United State Rivaroxaban Market Estimate by Application (USD MN)
  • United State Rivaroxaban Market Analysis by Distribution Channel (USD MN)
  • Canada Rivaroxaban Market Analysis by Strength (USD MN)
  • Canada Rivaroxaban Market Estimate by Application (USD MN)
  • Canada Rivaroxaban Market Estimate by Distribution Channel (USD MN)
  • Mexico Rivaroxaban Market Analysis by Strength (USD MN)
  • Mexico Rivaroxaban Market Estimate by Application (USD MN)
  • Mexico Rivaroxaban Market Estimate by Distribution Channel (USD MN)
  • Europe Rivaroxaban Market Analysis by Strength (USD MN)
  • Europe Rivaroxaban Market Estimate by Application (USD MN)
  • Europe Rivaroxaban Market Analysis by Distribution Channel (USD MN)
  • Europe Rivaroxaban Market Estimate by Country (USD MN)
  • United Kingdom Rivaroxaban Market Analysis by Strength (USD MN)
  • United Kingdom Rivaroxaban Market Estimate by Application (USD MN)
  • United Kingdom Rivaroxaban Market Analysis by Distribution Channel (USD MN)
  • France Rivaroxaban Market Analysis by Strength (USD MN)
  • France Rivaroxaban Market Estimate by Application (USD MN)
  • France Rivaroxaban Market Analysis by Distribution Channel (USD MN)
  • Germany Rivaroxaban Market Analysis by Strength (USD MN)
  • Germany Rivaroxaban Market Estimate by Application (USD MN)
  • Germany Rivaroxaban Market Analysis by Distribution Channel (USD MN)
  • Italy Rivaroxaban Market Analysis by Strength (USD MN)
  • Italy Rivaroxaban Market Estimate by Application (USD MN)
  • Italy Rivaroxaban Market Analysis by Distribution Channel (USD MN)
  • Russia Rivaroxaban Market Analysis by Strength (USD MN)
  • Russia Rivaroxaban Market Estimate by Application (USD MN)
  • Russia Rivaroxaban Market Analysis by Distribution Channel (USD MN)
  • Spain Rivaroxaban Market Analysis by Strength (USD MN)
  • Spain Rivaroxaban Market Estimate by Application (USD MN)
  • Spain Rivaroxaban Market Analysis by Distribution Channel (USD MN)
  • Rest of Europe Rivaroxaban Market Analysis by Strength (USD MN)
  • Rest of Europe Rivaroxaban Market Estimate by Application (USD MN)
  • Rest of Europe Rivaroxaban Market Analysis by Distribution Channel (USD MN)
  • Asia Pacific Rivaroxaban Market Analysis by Strength (USD MN)
  • Asia Pacific Rivaroxaban Market Estimate by Application (USD MN)
  • Asia Pacific Rivaroxaban Market Analysis by Distribution Channel (USD MN)
  • Asia Pacific Rivaroxaban Market Estimate by Country (USD MN)
  • China Rivaroxaban Market Analysis by Strength (USD MN)
  • China Rivaroxaban Market Estimate by Application (USD MN)
  • China Rivaroxaban Market Analysis by Distribution Channel (USD MN)
  • Japan Rivaroxaban Market Analysis by Strength (USD MN)
  • Japan Rivaroxaban Market Estimate by Application (USD MN)
  • Japan Rivaroxaban Market Analysis by Distribution Channel (USD MN)
  • India Rivaroxaban Market Analysis by Strength (USD MN)
  • India Rivaroxaban Market Estimate by Application (USD MN)
  • India Rivaroxaban Market Analysis by Distribution Channel (USD MN)
  • South Korea Rivaroxaban Market Analysis by Strength (USD MN)
  • South Korea Rivaroxaban Market Estimate by Application (USD MN)
  • South Korea Rivaroxaban Market Analysis by Distribution Channel (USD MN)
  • Australia Rivaroxaban Market Analysis by Strength (USD MN)
  • Australia Rivaroxaban Market Estimate by Application (USD MN)
  • Australia Rivaroxaban Market Analysis by Distribution Channel (USD MN)
  • Rest of Asia Pacific Rivaroxaban Market Analysis by Strength (USD MN)
  • Rest of Asia Pacific Rivaroxaban Market Estimate by Application (USD MN)
  • Rest of Asia Pacific Rivaroxaban Market Analysis by Distribution Channel (USD MN)
  • Latin America Rivaroxaban Market Analysis by Strength (USD MN)
  • Latin America Rivaroxaban Market Estimate by Application (USD MN)
  • Latin America Rivaroxaban Market Analysis by Distribution Channel (USD MN)
  • Latin America Rivaroxaban Market Estimate by Country (USD MN)
  • Brazil Rivaroxaban Market Analysis by Strength (USD MN)
  • Brazil Rivaroxaban Market Estimate by Application (USD MN)
  • Brazil Rivaroxaban Market Analysis by Distribution Channel (USD MN)
  • Argentina Rivaroxaban Market Analysis by Strength (USD MN)
  • Argentina Rivaroxaban Market Estimate by Application (USD MN)
  • Argentina Rivaroxaban Market Analysis by Distribution Channel (USD MN)
  • Peru Rivaroxaban Market Analysis by Strength (USD MN)
  • Peru Rivaroxaban Market Estimate by Application (USD MN)
  • Peru Rivaroxaban Market Analysis by Distribution Channel (USD MN)
  • Chile Rivaroxaban Market Analysis by Strength (USD MN)
  • Chile Rivaroxaban Market Estimate by Application (USD MN)
  • Chile Rivaroxaban Market Analysis by Distribution Channel (USD MN)
  • Rest of Latin America Rivaroxaban Market Analysis by Strength (USD MN)
  • Rest of Latin America Rivaroxaban Market Estimate by Application (USD MN)
  • Rest of Latin America Rivaroxaban Market Analysis by Distribution Channel (USD MN)
  • Middle East & Africa Rivaroxaban Market Analysis by Strength (USD MN)
  • Middle East & Africa Rivaroxaban Market Estimate by Application (USD MN)
  • Middle East & Africa Rivaroxaban Market Analysis by Distribution Channel (USD MN)
  • Middle East & Africa Rivaroxaban Market Estimate by Country (USD MN)
  • Saudi Arabia Rivaroxaban Market Analysis by Strength (USD MN)
  • Saudi Arabia Rivaroxaban Market Estimate by Application (USD MN)
  • Saudi Arabia Rivaroxaban Market Analysis by Distribution Channel (USD MN)
  • UAE Rivaroxaban Market Analysis by Strength (USD MN)
  • UAE Rivaroxaban Market Estimate by Application (USD MN)
  • UAE Rivaroxaban Market Analysis by Distribution Channel (USD MN)
  • Israel Rivaroxaban Market Analysis by Strength (USD MN)
  • Israel Rivaroxaban Market Estimate by Application (USD MN)
  • Israel Rivaroxaban Market Analysis by Distribution Channel (USD MN)
  • South Africa Rivaroxaban Market Analysis by Strength (USD MN)
  • South Africa Rivaroxaban Market Estimate by Application (USD MN)
  • South Africa Rivaroxaban Market Analysis by Distribution Channel (USD MN)
  • Rest of Middle East and Africa Rivaroxaban Market Analysis by Strength (USD MN)
  • Rest of Middle East and Africa Rivaroxaban Market Estimate by Application (USD MN)
  • Rest of Middle East and Africa Rivaroxaban Market Analysis by Distribution Channel (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
 
LIST OF FIGURES
  • Research Scope of Rivaroxaban Report
  • Market Research Process
  • Market Research Methodology
  • Global Rivaroxaban Market Size, by Region (2019)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Strength
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Rivaroxaban Market Analysis by Strength
  • Global Rivaroxaban Market Analysis by Application
  • Global Rivaroxaban Market Analysis in Deep Vein Thrombosis Prophylaxis by Region
  • Global Rivaroxaban Market Analysis in Pulmonary Embolism by Region
  • Global Rivaroxaban Market Analysis by Distribution Channel
  • Global Rivaroxaban Market Analysis in Hospital Pharmacies by Region
  • Global Rivaroxaban Market Analysis in Retail Pharmacies by Region
  • Global Rivaroxaban Market Analysis in Online Pharmacies by Region
  • Global Rivaroxaban Market by Revenue
  • North America Rivaroxaban Market by Revenue
  • Europe Rivaroxaban Market by Revenue
  • Asia Pacific Rivaroxaban Market by Revenue
  • Latin America Rivaroxaban Market by Revenue
  • Middle East & Africa Rivaroxaban Market by Revenue
  • Recent Development in Rivaroxaban Industry
  • Company Market Share Analysis, 2019
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Related Categories
Pharmaceuticals
Related Reports
Global Tigecycline Market Insights, Forecast to 2025

Tigecycline Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the  read more..


Global Caffeine Market Insights, Forecast to 2025

Caffeine Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the forecast  read more..


Global Rabies Vaccine Market Insights, Forecast to 2025

Rabies Vaccine Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the  read more..


United States Parkinsons Disease Drug Market Report 2018-2025

The United States Parkinsons Disease Drug market research report is the study prepared by analysts, which contain a detailed analysis of drivers,  read more..


Global Radiopharmaceuticals Market Insights, Forecast to 2025

Radiopharmaceuticals Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under  read more..


Global Neurorehabilitation System Market Research Report

The report on the Global Neurorehabilitation System Market gives an estimation of the development of the market based on historical studies and also  read more..


Global Molecular Biology Kits And Reagents Market Research Report

The report on the Global Molecular Biology Kits And Reagents Market gives an estimation of the development of the market based on historical studies and  read more..


Global High Acuity Care Information Systems Market Research Report

The report on the Global High Acuity Care Information Systems Market gives an estimation of the development of the market based on historical studies and  read more..


Global Regenerative Medicine Market Research Report

The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013.   A number of factors such as increasing bone related  read more..


Global Skin Cancer Diagnostics Market Research Report

The report on the Global Skin Cancer Diagnostics Market gives an estimation of the development of the market based on historical studies and also  read more..